IL2RB and ovarian cancer: Favorable to the use of NK cells as therapeutic target in ovarian cancer treatment, our results showed that ascites, as a tumor environment, did not affect the expression of the CD25, CD122 and CD215 molecules, which comprise the receptors for IL-2 and IL15 cytokines.